reversal agents Archives - Cardiac Rhythm News

Cardiac Rhythm News Cardiac Rhythm News is a one-stop source of news and opinion in the Cardiac Rhythm management world.

US FDA accepts Biologics License Application resubmission of reversal agent andexanet alfa

Latest News

US FDA accepts Biologics License Application resubmission of reversal agent andexanet alfa

Angela O'Neill- 15th August 2017

0

Final Phase III results support safety of idarucizumab as reversal agent for dabigatran etexilate mesylate

Latest News

Final Phase III results support safety of idarucizumab as reversal agent for dabigatran etexilate mesylate

amanda- 12th July 2017

0

Boehringer Ingelheim launches RE-VECTO global programme to explore idarucizumab use in clinical practice

Latest News

Boehringer Ingelheim launches RE-VECTO global programme to explore idarucizumab use in clinical practice

Angela O'Neill- 16th August 2016

0

Idarucizumab licensed in Europe as specific reversal agent of dabigatran

Latest News

Idarucizumab licensed in Europe as specific reversal agent of dabigatran

BIBA Publishing- 26th November 2015

0